BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34648817)

  • 1. Cavitary retinoblastoma: A review of literature.
    Raval V; Kaliki S
    Surv Ophthalmol; 2022; 67(3):723-728. PubMed ID: 34648817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors.
    Zheng Y; Froehler MT; Friedman DL; Daniels AB
    Ophthalmol Retina; 2021 May; 5(5):479-485. PubMed ID: 32853834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
    Rojanaporn D; Kaliki S; Bianciotto CG; Iturralde JC; Say EA; Shields CL
    Arch Ophthalmol; 2012 May; 130(5):585-90. PubMed ID: 22652844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trilateral retinoblastoma: a literature review, 1971-2004.
    Mouratova T
    Bull Soc Belge Ophtalmol; 2005; (297):25-35. PubMed ID: 16281731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE RECOGNITION OF CAVITARY RETINOBLASTOMA TUMORS: Implications for Management and Genetic Analysis.
    Chaudhry S; Onadim Z; Sagoo MS; Reddy MA
    Retina; 2018 Apr; 38(4):782-787. PubMed ID: 28368972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoblastoma.
    Rao R; Honavar SG
    Indian J Pediatr; 2017 Dec; 84(12):937-944. PubMed ID: 28620731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma in Turkey: results from a tertiary care center in Ankara.
    Gündüz K; Köse K; Kurt RA; Süren E; Taçyildiz N; Dinçaslan H; Ünal E; Erden E; Heper AO
    J Pediatr Ophthalmol Strabismus; 2013; 50(5):296-303. PubMed ID: 23937863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Update of Retinoblastoma in China: Three-Decade Changes in Epidemiology, Clinical Features, Treatments, and Outcomes.
    Luo Y; Zhou C; He F; Fan J; Wen X; Ding Y; Han Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Sun H; Xiao Y; Wu L; Wang J; Li Y; Yang H; Yu J; Gong J; Xu Y; Wen Y; Gao Z; Mei L; Ye J; Liu H; Chen Z; Xue S; Liu R; Chen H; Lu W; Liao H; Guo Q; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Guanghong Z; Wubuli M; Huiyu G; Wang X; He Y; Sheng X; Wang Q; Tan J; Liang J; Sun X; Zhang J; Ji X; Jin L; Zhao J; Yang X; Jia R; Fan X
    Am J Ophthalmol; 2022 Apr; 236():193-203. PubMed ID: 34626572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a formal program for retinoblastoma: Feasibility of clinical coordination across borders and impact on outcome.
    Al-Haddad C; Bashour Z; Farah L; Bayram L; Merabe Z; Ma'luf R; Alameddine R; Eid T; Geara F; Wilson M; Brennan R; Jeha S; Ghanem K; Yousef RA; Farah R; Noun P; Yassine N; Inati A; Muwakkit S; Abboud M; Tarek N; Hamideh D; Saab R
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27959. PubMed ID: 31423715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cavitary retinoblastoma: clinical observations.
    Rishi P; Sharma U; Sharma T
    Eye (Lond); 2020 Apr; 34(4):704-710. PubMed ID: 31534184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoblastoma: Can you see it?
    Community Pract; 2016 Oct; 89(10):26-8. PubMed ID: 29944219
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
    Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL
    J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country: Analysis of 478 Patients.
    Yousef YA; Al-Nawaiseh I; Mehyar M; Sultan I; Al-Hussaini M; Jaradat I; Mohammad M; AlJabari R; Abu-Yaghi N; Rodriguez-Galindo C; Qaddoumi I; Wilson M
    Ophthalmology; 2021 Jan; 128(1):130-137. PubMed ID: 32682835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of retinoblastoma.
    Fabian ID; Onadim Z; Karaa E; Duncan C; Chowdhury T; Scheimberg I; Ohnuma SI; Reddy MA; Sagoo MS
    Oncogene; 2018 Mar; 37(12):1551-1560. PubMed ID: 29321667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cavitary changes in retinoblastoma: relationship to chemoresistance.
    Mashayekhi A; Shields CL; Eagle RC; Shields JA
    Ophthalmology; 2005 Jun; 112(6):1145-50. PubMed ID: 15885779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma and vision.
    Warda O; Naeem Z; Roelofs KA; Sagoo MS; Reddy MA
    Eye (Lond); 2023 Apr; 37(5):797-808. PubMed ID: 34987197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of retinoblastoma.
    Islam F; Zafar SN; Siddiqui SN; Khan A
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):566-9. PubMed ID: 23930873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital retinoblastoma: An update.
    Honavar SG; Manjandavida FP; Reddy VAP
    Indian J Ophthalmol; 2017 Jun; 65(6):435-442. PubMed ID: 28643706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global retinoblastoma studies: A review.
    Vempuluru VS; Maniar A; Kaliki S
    Clin Exp Ophthalmol; 2024 Apr; 52(3):334-354. PubMed ID: 38263682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile, management, and outcome of retinoblastoma in singapore.
    Lim FP; Soh SY; Iyer JV; Tan AM; Swati H; Quah BL
    J Pediatr Ophthalmol Strabismus; 2013; 50(2):106-12. PubMed ID: 23244241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.